- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06513637
12 Lead ECG Database
12-Lead ECG Database
The purpose of this investigation is to collect a database of simultaneous electrocardiogram (ECG) recordings from the SANSA device and a reference 12-lead ECG recording device.
The purpose of this database is to aid development and evaluation of algorithms to detect cardiac arrhythmias and other parameters from the electrocardiogram. Example analyses that may utilize this database are ECG vector transformations and ECG waveform timing analyses.
The study is for scientific purposes and does not intend to diagnose, cure, mitigate, treat, or prevent any disease and does not involve any medical procedures.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Jill Fricke, BS
- Phone Number: 1-888-726-7239
- Email: jill.fricke@huxleymed.com
Study Contact Backup
- Name: Brennan Torstrick, PhD
- Phone Number: 1-888-726-7239
- Email: brennan@huxleymed.com
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- are 18 years of age or older.
- are able to read, understand, and sign informed consent documentation.
- are willing to undergo simultaneous recordings with the Sansa and 12-lead ECG device.
Exclusion Criteria:
- exhibit deformities of the chest (e.g., pronounced scarring, pectus carinatum) that would interfere with sensor placement
- have broken or injured skin that would interfere with sensor placement
- are known to experience adverse reactions to medical-grade adhesive
- are pregnant
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
No specified primary endpoint
Time Frame: Subjects will participate in a single visit. Subjects will be considered enrolled upon signing the informed consent. The entire duration of enrollment is expected to be less than one hour and no more than six hours
|
This data collection protocol does not have any specific data analysis endpoints. Its purpose is to collect data to be included in an ECG database that may be used for various future analyses. The number, severity, and device/comparator relatedness of AEs reported while subjects undergo study procedures will be reported. |
Subjects will participate in a single visit. Subjects will be considered enrolled upon signing the informed consent. The entire duration of enrollment is expected to be less than one hour and no more than six hours
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CP-10002 12 Lead ECG Database
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Arrhythmias, Cardiac
-
Medtronic BRCCompletedAtrial Fibrillation | Risk of Cardiac ArrhythmiasNetherlands, Germany, Austria, Belgium, Canada, Czech Republic, Russian Federation, Slovakia
-
Medical University of LodzRecruiting
-
Boston Scientific CorporationRecruitingCardiac ArrythmiasUnited States, Italy, Monaco
-
Centro Cardiologico MonzinoMinistry of Health, ItalyCompletedCardiac ArrhythmiaItaly
-
EPD Solutions, A Philips CompanyPhilips HealthcareTerminatedCardiac ArrhythmiaUnited States
-
EPD Solutions, A Philips CompanyWithdrawn
-
Zoll Medical CorporationCompletedCardiac ArrhythmiaUnited States
-
Emory UniversityCompleted
-
Qompium NVCompleted
-
Blackpool Teaching Hospitals NHS Foundation TrustUnknownCardiac ArrhythmiaUnited Kingdom
Clinical Trials on 12-Lead ECG and home sleep study (HST) diagnostics
-
Qompium NVCompleted
-
Konya City HospitalRecruitingMyocardial Infarction | Chest Pain | Acute Myocardial Infarction (AMI) | Left Bundle Branch Block | Coronary Occlusion/ThrombosisTurkey (Türkiye)
-
Mayo ClinicActive, not recruitingHypertrophic CardiomyopathyUnited States
-
Rigshospitalet, DenmarkNykøbing Falster County Hospital; Region SjællandUnknown
-
Hull University Teaching Hospitals NHS TrustCompleted
-
Seoul National University HospitalNot yet recruitingLeft Ventricular Systolic Dysfunction
-
Monash UniversityNational Health and Medical Research Council, Australia; Curtin UniversityActive, not recruitingHeart Failure | Atrial Fibrillation | Hypercholesterolemia | Healthy Ageing | Myocardial DysfunctionAustralia
-
Gillette Children's Specialty HealthcareTerminatedDravet Syndrome | Lennox-Gastaut SyndromeUnited States
-
Watson PharmaceuticalsCompletedAnemia, Iron-Deficiency | Kidney Failure, ChronicUnited States, Puerto Rico